Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin forHelicobacter pyloriinfection in Singapore? Results of a time trend analysis

Sa1656 An Update on Antibiotic Resistant Helicobacter pylori Among Chinese Population of Asia

(2011) Fock Kwong Ming et al.   GASTROINTESTINAL ENDOSCOPY

High Helicobacter pylori Resistance to Metronidazole but Zero or Low Resistance to Clarithromycin, Levofloxacin, and Other Antibiotics in Malaysia

(2011) Khean-Lee Goh et al.   HELICOBACTER

Optimal therapy for Helicobacter pylori infections

(2011) Emiko Rimbara et al.   Nature Reviews Gastroenterology & Hepatology

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

The Evolution of Helicobacter pylori Antibiotics Resistance Over 10 Years in Beijing, China

(2010) Wen Gao et al.   HELICOBACTER

Is Antimicrobial Susceptibility Testing Necessary Before First-line Treatment for Helicobacter pylori Infection? -Meta-analysis of Randomized Controlled Trials-

(2010) Yuan Wenzhen et al.   INTERNAL MEDICINE

Resistance ofHelicobacter pylorito antibiotics from 2000 to 2009 in Shanghai

(2010) Qin-Juan Sun   WORLD JOURNAL OF GASTROENTEROLOGY

Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection

(2009) K Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Epidemiology ofHelicobacter pyloriinfection and gastric cancer in Asia

(2009) Kwong Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Asia–Pacific consensus guidelines on gastric cancer prevention

(2008) Kwong Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY